These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28672834)

  • 41. Peptide Mix from
    Gasu EN; Ahor HS; Borquaye LS
    Biomed Res Int; 2019; 2019():5313918. PubMed ID: 31662981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous Antibiofilm and Antiviral Activities of an Engineered Antimicrobial Peptide during Virus-Bacterium Coinfection.
    Melvin JA; Lashua LP; Kiedrowski MR; Yang G; Deslouches B; Montelaro RC; Bomberger JM
    mSphere; 2016; 1(3):. PubMed ID: 27303744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.
    Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M
    Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 45. Synergistic in vitro effects of indocyanine green and ethylenediamine tetraacetate-mediated antimicrobial photodynamic therapy combined with antibiotics for resistant bacterial biofilms in diabetic foot infection.
    Li X; Huang W; Zheng X; Chang S; Liu C; Cheng Q; Zhu S
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():300-308. PubMed ID: 30633998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.
    Pulido D; Prats-Ejarque G; Villalba C; Albacar M; Moussaoui M; Andreu D; Volkmer R; Torrent M; Boix E
    Eur J Med Chem; 2018 May; 152():590-599. PubMed ID: 29763807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A combination of cis-2-decenoic acid and antibiotics eradicates pre-established catheter-associated biofilms.
    Rahmani-Badi A; Sepehr S; Mohammadi P; Soudi MR; Babaie-Naiej H; Fallahi H
    J Med Microbiol; 2014 Nov; 63(Pt 11):1509-1516. PubMed ID: 25082943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide.
    Grassi L; Maisetta G; Maccari G; Esin S; Batoni G
    Front Chem; 2017; 5():24. PubMed ID: 28443279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm.
    Banin E; Brady KM; Greenberg EP
    Appl Environ Microbiol; 2006 Mar; 72(3):2064-9. PubMed ID: 16517655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms.
    Baker P; Hill PJ; Snarr BD; Alnabelseya N; Pestrak MJ; Lee MJ; Jennings LK; Tam J; Melnyk RA; Parsek MR; Sheppard DC; Wozniak DJ; Howell PL
    Sci Adv; 2016 May; 2(5):e1501632. PubMed ID: 27386527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates.
    Alabdullatif M; Atreya CD; Ramirez-Arcos S
    Transfusion; 2018 Aug; 58(8):2013-2021. PubMed ID: 29687885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic Action of Phage and Antibiotics: Parameters to Enhance the Killing Efficacy Against Mono and Dual-Species Biofilms.
    Akturk E; Oliveira H; Santos SB; Costa S; Kuyumcu S; Melo LDR; Azeredo J
    Antibiotics (Basel); 2019 Jul; 8(3):. PubMed ID: 31349628
    [No Abstract]   [Full Text] [Related]  

  • 53. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms.
    Zacchino SA; Butassi E; Cordisco E; Svetaz LA
    Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.
    Alves DR; Perez-Esteban P; Kot W; Bean JE; Arnot T; Hansen LH; Enright MC; Jenkins AT
    Microb Biotechnol; 2016 Jan; 9(1):61-74. PubMed ID: 26347362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of biofilm removal capacity of a broad host range bacteriophage JHP against Pseudomonas aeruginosa.
    Shafique M; Alvi IA; Abbas Z; Ur Rehman S
    APMIS; 2017 Jun; 125(6):579-584. PubMed ID: 28418081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
    Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
    Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
    PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glutathione-Disrupted Biofilms of Clinical Pseudomonas aeruginosa Strains Exhibit an Enhanced Antibiotic Effect and a Novel Biofilm Transcriptome.
    Klare W; Das T; Ibugo A; Buckle E; Manefield M; Manos J
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4539-51. PubMed ID: 27161630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Matrix Polysaccharides and SiaD Diguanylate Cyclase Alter Community Structure and Competitiveness of
    Chew SC; Yam JKH; Matysik A; Seng ZJ; Klebensberger J; Givskov M; Doyle P; Rice SA; Yang L; Kjelleberg S
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial peptides Pep19-2.5 and Pep19-4LF inhibit Streptococcus mutans growth and biofilm formation.
    Jannadi H; Correa W; Zhang Z; Brandenburg K; Oueslati R; Rouabhia M
    Microb Pathog; 2019 Aug; 133():103546. PubMed ID: 31112769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.